Company intelligence / Profile preview

Alere Inc.

Waltham , Massachusetts , United States dnb.com ↗

Ownership: Public · ALR
Employees: ~1848
Development stage: Commercial

Overview

Alere was a global leader in rapid point-of-care diagnostic tests for infectious diseases, cardiometabolic conditions, and toxicology. The company developed widely used products such as the INRatio PT/INR monitor system and iCup drug test kits. In its final years before acquisition by Abbott Laboratories in October 2017 for $5.3 billion, Alere was a market leader with a broad portfolio of commercialized products[1][2][5].

Therapeutic areas: OtherCardiovascularInfectious Diseases
Modalities: Rapid immunoassaysMolecular diagnosticsPoint-of-care diagnostic devices
Industry: Molecular Diagnostics

Drug pipeline

1 asset

Triage drug of abuse panel

Commercial

Indications: Drug abuse detection

Partnerships

P&G (Swiss Precision Diagnostics joint venture)

Financials

Market cap: $44.2M
Total revenue: $182.7M
Enterprise value: $38.4M

Beyond the preview

Go deeper on Alere Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alere Inc..

Explore the full profile